219 related articles for article (PubMed ID: 16680544)
1. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
[TBL] [Abstract][Full Text] [Related]
2. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
Glotzer TV; Daoud EG; Wyse DG; Singer DE; Ezekowitz MD; Hilker C; Miller C; Qi D; Ziegler PD
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):474-80. PubMed ID: 19843914
[TBL] [Abstract][Full Text] [Related]
3. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS.
Daoud EG; Glotzer TV; Wyse DG; Ezekowitz MD; Hilker C; Koehler J; Ziegler PD;
Heart Rhythm; 2011 Sep; 8(9):1416-23. PubMed ID: 21699833
[TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
[TBL] [Abstract][Full Text] [Related]
7. Everything counts in large amounts: device-detected atrial high-rate arrhythmias.
Viles-Gonzalez JF; Halperin JL
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):471-3. PubMed ID: 19843913
[No Abstract] [Full Text] [Related]
8. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation variability on long-term monitoring of implantable cardiac rhythm management devices.
Kaplan RM; Ziegler PD; Koehler J; Glotzer TV; Passman RS
Clin Cardiol; 2017 Nov; 40(11):1044-1048. PubMed ID: 28800149
[TBL] [Abstract][Full Text] [Related]
12. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
13. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J
J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211
[TBL] [Abstract][Full Text] [Related]
14. Detection of paroxysmal atrial fibrillation or flutter in patients with acute ischemic stroke or transient ischemic attack by Holter monitoring.
Thakkar S; Bagarhatta R
Indian Heart J; 2014; 66(2):188-92. PubMed ID: 24814113
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).
Santini M; De Ferrari GM; Pandozi C; Alboni P; Capucci A; Disertori M; Gaita F; Lombardi F; Maggioni AP; Mugelli A; Salerno-Uriarte JA; Sermasi S; Schwartz PJ;
Ital Heart J; 2004 Mar; 5(3):205-13. PubMed ID: 15119503
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
[TBL] [Abstract][Full Text] [Related]
17. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
[TBL] [Abstract][Full Text] [Related]
18. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
[TBL] [Abstract][Full Text] [Related]
19. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
20. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
Schuster P; Faerestrand S; Ohm OJ
Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
